Registered entities
Oncocross Co., Ltd.
Reg. No. 482-86-00109South Korea
Innovation
46 patent families (16 granted) — focus: Human necessities, Physics & computing, Chemistry & metallurgy; filing pace slowing. Cited 643 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 16 |
| 2022 | 21 |
| 2023 | 16 |
| 2024 | 12 |
| 2025 | 8 |
| 2026 | 5 |
Social engagement
Social engagement: 339 social following, 10 posts in the last 12 months — top quartile of its industry.
Investor mix
13 investors on record; lead investors include Smile Gate Investment, GNTech Venture Capital, ID Ventures, MAGNA Investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 31% |
| Private equity | 3 | 23% |
| Accelerator & incubator | 1 | 8% |
| Other / undisclosed | 5 | 38% |
Recent activity
26 May 2026
Partnership
Human & Bio
21 Apr 2026
Event
AACR 2026
20 Apr 2026
Leadership hire
CTO and Vice President